JPS59128329A - 抗ウィルス剤 - Google Patents

抗ウィルス剤

Info

Publication number
JPS59128329A
JPS59128329A JP58001594A JP159483A JPS59128329A JP S59128329 A JPS59128329 A JP S59128329A JP 58001594 A JP58001594 A JP 58001594A JP 159483 A JP159483 A JP 159483A JP S59128329 A JPS59128329 A JP S59128329A
Authority
JP
Japan
Prior art keywords
active ingredient
pentagalloylglucose
drug
antiviral agent
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58001594A
Other languages
English (en)
Japanese (ja)
Other versions
JPH031289B2 (enExample
Inventor
Yasuo Tanaka
康雄 田中
Masayuki Takechi
武智　昌幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KINKIDAIGAKU
Original Assignee
KINKIDAIGAKU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KINKIDAIGAKU filed Critical KINKIDAIGAKU
Priority to JP58001594A priority Critical patent/JPS59128329A/ja
Publication of JPS59128329A publication Critical patent/JPS59128329A/ja
Publication of JPH031289B2 publication Critical patent/JPH031289B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP58001594A 1983-01-07 1983-01-07 抗ウィルス剤 Granted JPS59128329A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58001594A JPS59128329A (ja) 1983-01-07 1983-01-07 抗ウィルス剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58001594A JPS59128329A (ja) 1983-01-07 1983-01-07 抗ウィルス剤

Publications (2)

Publication Number Publication Date
JPS59128329A true JPS59128329A (ja) 1984-07-24
JPH031289B2 JPH031289B2 (enExample) 1991-01-10

Family

ID=11505829

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58001594A Granted JPS59128329A (ja) 1983-01-07 1983-01-07 抗ウィルス剤

Country Status (1)

Country Link
JP (1) JPS59128329A (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
WO1998042350A1 (en) * 1997-03-21 1998-10-01 Cheil Jedang Corporation Cholesterol lowering pharmaceutical composition
WO2003061554A3 (en) * 2002-01-26 2003-11-13 Micro Science Tech Co Ltd Composition containing moutan root bark extract as active ingredient
KR100839099B1 (ko) 2007-03-08 2008-06-19 원광대학교산학협력단 오배자 및 목단피 추출물을 함유하는 돼지 유행성 설사바이러스의 치료 및 예방용 조성물
WO2009123183A1 (ja) * 2008-03-31 2009-10-08 国立大学法人広島大学 抗ウイルス剤および抗ウイルス用組成物
WO2010067869A1 (ja) * 2008-12-12 2010-06-17 国立大学法人広島大学 抗ウイルス剤および抗ウイルス用組成物
CN103012510A (zh) * 2012-12-03 2013-04-03 北京工业大学 一种1,2,3,4,6-五没食子酰葡萄糖对照品的制备方法
CN103800524A (zh) * 2014-01-19 2014-05-21 逯玲 一种治疗热毒炽盛型水痘的中药合剂
CN103800468A (zh) * 2012-11-12 2014-05-21 天津瑞贝特科技发展有限公司 一种高蛋白营养免疫组合物及其制备方法
KR101398426B1 (ko) * 2007-03-16 2014-06-18 원광대학교산학협력단 항균 및 항바이러스 활성을 갖는 오배자 및 목단피추출물을 함유하는 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791922A (en) * 1980-11-27 1982-06-08 Yasuo Tanaka Antiviral agent of external use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791922A (en) * 1980-11-27 1982-06-08 Yasuo Tanaka Antiviral agent of external use

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
WO1998042350A1 (en) * 1997-03-21 1998-10-01 Cheil Jedang Corporation Cholesterol lowering pharmaceutical composition
WO2003061554A3 (en) * 2002-01-26 2003-11-13 Micro Science Tech Co Ltd Composition containing moutan root bark extract as active ingredient
KR100839099B1 (ko) 2007-03-08 2008-06-19 원광대학교산학협력단 오배자 및 목단피 추출물을 함유하는 돼지 유행성 설사바이러스의 치료 및 예방용 조성물
KR101398426B1 (ko) * 2007-03-16 2014-06-18 원광대학교산학협력단 항균 및 항바이러스 활성을 갖는 오배자 및 목단피추출물을 함유하는 조성물
WO2009123183A1 (ja) * 2008-03-31 2009-10-08 国立大学法人広島大学 抗ウイルス剤および抗ウイルス用組成物
JP2014012715A (ja) * 2008-03-31 2014-01-23 Hiroshima Univ ロタウイルス属の非エンベロープウイルスに対する抗ウイルス剤および抗ウイルス用組成物
JP5421901B2 (ja) * 2008-03-31 2014-02-19 国立大学法人広島大学 エンテロウイルス属の非エンベロープウイルスに対する抗ウイルス剤および抗ウイルス用組成物
US9445605B2 (en) 2008-03-31 2016-09-20 Hiroshima University Method for disinfection or infection control against a non-enveloped virus
WO2010067869A1 (ja) * 2008-12-12 2010-06-17 国立大学法人広島大学 抗ウイルス剤および抗ウイルス用組成物
CN103800468A (zh) * 2012-11-12 2014-05-21 天津瑞贝特科技发展有限公司 一种高蛋白营养免疫组合物及其制备方法
CN103012510A (zh) * 2012-12-03 2013-04-03 北京工业大学 一种1,2,3,4,6-五没食子酰葡萄糖对照品的制备方法
CN103800524A (zh) * 2014-01-19 2014-05-21 逯玲 一种治疗热毒炽盛型水痘的中药合剂

Also Published As

Publication number Publication date
JPH031289B2 (enExample) 1991-01-10

Similar Documents

Publication Publication Date Title
Schwarb et al. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations
US10695391B2 (en) Extract from Indigo Naturalis and a process for preparing the same
JPS59128329A (ja) 抗ウィルス剤
DAVISON et al. The distribution of certain non-narcotic analgetic agents in the CNS of several species
CN104474551A (zh) 褪黑素磷脂复合物、其透皮给药制剂及其制备方法
Friedhoff et al. Comparison of the metabolism of 3, 4-dimethoxyphenylethylamine and mescaline in humans
CN110917135B (zh) 能有效溶解奥硝唑或左奥硝唑的溶剂体系及其注射液
CN100577677C (zh) 络石藤总木脂素提取物,提取方法及该提取物和其中有效成分的医药用途
JP2002543125A (ja) リンパ増殖性および自己免疫症状の治療のための、ボスウェリアセラータ（Ｂｏｓｗｅｌｌｉａｓｅｒｒａｔａ）ゴム樹脂由来ボスウェリン酸の組成物
Dempski et al. In vitro release and in vivo penetration studies of a topical steroid from nonaqueous vehicles
CN106491680B (zh) 一种预防或治疗老年痴呆的中药组合物及其制备方法
US4465673A (en) Pentagalloylglucose antiviral composition
JP7307715B2 (ja) オートファジーの促進剤としての相乗作用組成物
CN105949042A (zh) 一种加巴喷丁的药物组合物及其医药用途
CN105535076B (zh) 由当归、蒺藜制成的治疗白癜风的药物及其制法与用途
CN104739923B (zh) 一种用于治疗慢性肾炎的肾茶总酚及其制备方法
JP2816664B2 (ja) 抗痴呆症剤
JPS6250449B2 (enExample)
CN103288914A (zh) 中药饿蚂蝗提取物的制备及抗老年性痴呆药物用途
CN119751351B (zh) 一种具有乙酰胆碱酯酶抑制活性的生物碱及其制备方法
CN116725952B (zh) 一种米诺地尔搽剂的制备方法
Ali et al. Paracetamol bioavailability from an elixir, a suspension and a new alcohol-free liquid dosage form in humans
Gisvold Enzymatic decomposition of digitalis glycosides III
Kundu et al. Esterase activity of chymotrypsin on O-DNP-L-tyrosine ethyl ester substrates
Nash et al. A study of propoxyphene and salicylate concentrations in human plasma following the administration of propoxyphene napsylate and aspirin